Join Our Expert Chat on August 19: When Will We Have a Vaccine and What Can We Do Until Then?

Seems like none of us can wait for the vaccine, but developing a safe and effective vaccine takes time. So, for our next Expert Chat we’ve invited a pharma/biotech attorney who’s an FDA veteran to explain the process for developing a vaccine. We’ll also pick the brain of an acclaimed director (to explore how live event organizers can adapt and thrive in the meantime).

Join Goldstar, Ethan McSweeny (Artistic Director of the American Shakespeare Center), and Denise Esposito (co-chair of Covington & Burling’s global Food, Drug, and Device Practice Group), for our Expert Chat on Wednesday, August 19 at 3:00pm Eastern Time

Goldstar CEO Jim McCarthy will also have the latest results from our ongoing survey of Goldstar subscribers and a look at the consumer Return Readiness Score.

Register here.

More about our guests: 

Denise Esposito is the co-chair of Covington & Burling’s global Food, Drug, and Device Practice Group. She provides strategic, policy, and regulatory advice to biotechnology, pharmaceutical, and medical device clients, with a focus on matters that involve navigation of U.S. Food and Drug Administration (FDA) and the complex political and policy challenges faced by FDA-regulated companies. Ms. Esposito’s practice includes advising clients on marketing authorization strategies, expedited approval programs, life cycle management, and the promotion of medical products. She has worked with FDA, the Biomedical Advanced Research and Development Authority (BARDA), and other agencies involved in the U.S. government’s response to national public health emergencies and has been heavily involved in the industry’s response to the Coronavirus Disease 2019 (COVID-19) pandemic. 

Ms. Esposito has more than 25 years of experience representing clients in the life sciences industry. Prior to joining Covington, she served as the Chief of Staff to the FDA Commissioner, the Deputy Chief Counsel for Drugs and Biological Products in the FDA Office of the Chief Counsel, and the director of policy for FDA’s Center for Drug Evaluation and Research (CDER). Ms. Esposito was the general counsel of Emergent BioSolutions and a partner at WilmerHale, prior to joining FDA in 2010.

Ethan McSweeny was named Artistic Director of American Shakespeare Center in June 2018 and made his Blackfriars directing debut with Julius Caesar followed by the world premiere of Julianne Wick Davis’ musical The Willard Suitcases.

His internationally acclaimed work over the past two decades has been distinguished by both its remarkable diversity and breadth of achievement. In New York, his direction includes the Broadway revival of Gore Vidal’s The Best Man (Tony Award nomination, Drama Desk and Outer Critics Circle awards) and the premiere of John Grisham’s A Time to Kill; the off-Broadway premieres of John Logan’s Never the Sinner (Outer Critics and Drama Desk awards) and Ellen McLaughlin’s adaptation of Aeschylus’ The Persians, as well as world premieres by Kate Fodor, Jason Grote, and Thomas Bradshaw, among others.

Ethan served as the Artistic Director of the Chautauqua Theatre Company from 2004- 2011; as a Trustee of SDC, the national labor union representing directors and choreographers, from 2005-2017; and as Treasurer on the inaugural board of the SDC Foundation since 2018. He received the first-ever undergraduate degree in Theatre and Dramatic Arts from Columbia University.

Sign Up for Emails